Workflow
神州细胞: 神州细胞2025年第一次临时股东会决议公告

Meeting Overview - The shareholders' meeting of Beijing Shenzhou Cell Biotechnology Group Co., Ltd. was held on June 23, 2025, at the company's research building in Beijing Economic and Technological Development Zone [1]. - A total of 143 ordinary shareholders attended the meeting, holding 354,393,180 voting rights, which accounted for 79.5788% of the company's total voting rights [1]. Voting Results - All proposed resolutions were approved during the meeting, with significant support from ordinary shareholders. For instance, one resolution received 98.4746% approval from ordinary shareholders [2][3]. - The voting results showed that the majority of votes were in favor, with a minimal percentage of dissenting votes and abstentions across various resolutions [2][3]. Legal Compliance - The meeting was convened in accordance with the Company Law and the company's articles of association, with the chairman Dr. Xie Liangzhi presiding over the meeting [1]. - The legal representatives confirmed that the meeting's procedures and voting results were compliant with relevant laws and regulations, ensuring the legitimacy of the proceedings [5][6].